PCCA recognized four individuals for their contributions to pharmacy compounding during its ThinkNext: International Seminar 2025, held October 9-11 in The Woodlands, Texas. The awards were presented to three pharmacists and one pharmacy technician for their achievements in innovation, advocacy, quality, patient care, and leadership.
Peter Koshland, PharmD, FAPC, owner of Koshland Pharm: Custom Compounding Pharmacy in San Francisco, California, received the 2025 M. George Webber, PhD, Compounding Pharmacist of the Year award. PCCA CEO Gus Bassani, PharmD, presented the award with Precision Health Holdings CEO Jim Smith and Board Members Chick Armstrong and Bryan Sparks.
“Peter is a visionary leader, a passionate advocate for the compounding pharmacy industry and a pharmacist whose commitment to excellence and integrity sets a standard for others to follow,” Bassani said. “His dedication to advancing the profession goes far beyond the walls of his own pharmacy. He is a vocal advocate for the industry, consistently engaging in dialogue about regulatory standards, quality assurance and patient care.”
Koshland serves on the Alliance for Pharmacy Compounding (APC) board of directors and is a PCCA Concierge Compounding member and Advisory Council alumnus. He has worked with PCCA to highlight the importance of high-quality ingredients and consistent compounding practices.
Katie Albers, CPhT, FAPC, pharmacy manager and co-owner of Impact Compounding in Tipp City, Ohio, was named the 2025 USA Compounding Technician of the Year. The award was presented by PCCA Senior Director of Member Relations Erin Michael, MBA, MS, CPhT, FAPC.
“Katie is a shining star,” Michael said. “As a technician/owner, she occupies a unique position within her pharmacy. Katie is never satisfied with the status quo and is always seeking ways to improve her business and patient outcomes. She’s known for her smart operational choices that elevate patient care and her never-ending pursuit of exemplary service to her patients and providers.”
Albers has developed relationships with other Concierge Compounding program members and has focused on education and innovative strategies to improve pharmacy operations.
Dawn Ipsen, PharmD, FAPC, FACA, owner and pharmacist of Kusler's Compounding Pharmacy in Snohomish, Washington, and Clark’s Compounding Pharmacy in Bellevue, Washington, received the 2025 L. David Sparks Advocacy Award. The award was presented by Precision Health Holdings Chief Strategy Officer Lizzie Harbin and Board Member Bryan Sparks.
“There are some people in this world who don’t just meet the standard — they become the standard,” Harbin said. “Dawn is one of those rare individuals who isn’t just worthy of this award — she lives it, exemplifies it and raises the bar for it every single day.”
“A relentless ambassador for compounding and PCCA, Dawn’s passion is infectious,” Sparks said. “She advocates for the profession at every opportunity — not for recognition, but because she genuinely believes in its ability to change lives.”
Ipsen’s advocacy includes education, professional development, and public policy. She was recently recognized as the 2025 Allied Industry Partner of the Year by the Washington State Veterinary Medical Association and participates in national industry conferences.
Matt Brensel, PharmD, vice president and compounding pharmacist at ScriptWorks Pharmacy in Walnut Creek, California, received the 2025 George Roentsch, RPh, New Innovator Award. PCCA Clinical Compounding Pharmacist Mark Gonzalez, PharmD, presented the award.
“George Roentsch set the bar high in the early development of compounding. In his short time in the field, Matt has already exemplified the innovation, collaboration and dedication that this award honors,” said Gonzalez, when presenting the award. “He integrates clinical pharmacy with compounding pharmacy — developing therapies that match exactly what patients need and backing his recommendations with clinical rationale.”
Brensel has introduced new systems at ScriptWorks to improve workflow, accuracy, and patient care while maintaining regulatory compliance.
PCCA provides products, education, and support to over 3,000 pharmacy members in the United States, Canada, Australia, and other countries. Founded in 1981, PCCA has supported pharmacy compounding for more than 40 years.
Precision Health Holdings is a strategic holding company that includes PCCA and other healthcare organizations, aiming to advance personalized medicine through shared leadership and resources.
For more information about PCCA, visit pccarx.com.
Alerts Sign-up